Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive adult-onset neurodegenerative disease that is often diagnosed with a delay due to initial non-specific symptoms. Therefore, reliable and easy-to-obtain biomarkers are an absolute necessity for earlier and more accurate diagnostics. Circula...

Full description

Bibliographic Details
Main Authors: Metka Ravnik Glavač, Massimo Mezzavilla, Ana Dolinar, Blaž Koritnik, Damjan Glavač
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/5/1316
_version_ 1797600905807265792
author Metka Ravnik Glavač
Massimo Mezzavilla
Ana Dolinar
Blaž Koritnik
Damjan Glavač
author_facet Metka Ravnik Glavač
Massimo Mezzavilla
Ana Dolinar
Blaž Koritnik
Damjan Glavač
author_sort Metka Ravnik Glavač
collection DOAJ
description Amyotrophic lateral sclerosis (ALS) is a rapidly progressive adult-onset neurodegenerative disease that is often diagnosed with a delay due to initial non-specific symptoms. Therefore, reliable and easy-to-obtain biomarkers are an absolute necessity for earlier and more accurate diagnostics. Circular RNAs (circRNAs) have already been proposed as potential biomarkers for several neurodegenerative diseases. In this study, we further investigated the usefulness of circRNAs as potential biomarkers for ALS. We first performed a microarray analysis of circRNAs on peripheral blood mononuclear cells of a subset of ALS patients and controls. Among the differently expressed circRNA by microarray analysis, we selected only the ones with a host gene that harbors the highest level of conservation and genetic constraints. This selection was based on the hypothesis that genes under selective pressure and genetic constraints could have a major role in determining a trait or disease. Then we performed a linear regression between ALS cases and controls using each circRNA as a predictor variable. With a False Discovery Rate (FDR) threshold of 0.1, only six circRNAs passed the filtering and only one of them remained statistically significant after Bonferroni correction: hsa_circ_0060762 and its host gene CSE1L. Finally, we observed a significant difference in expression levels between larger sets of patients and healthy controls for both hsa_circ_0060762 and CSE1L. CSE1L is a member of the importin β family and mediates inhibition of TDP-43 aggregation; the central pathogenicity in ALS and hsa_circ_0060762 has binding sites for several miRNAs that have been already proposed as biomarkers for ALS. In addition, receiver operating characteristics curve analysis showed diagnostic potential for CSE1L and hsa_circ_0060762. Hsa_circ_0060762 and CSE1L thus represent novel potential peripheral blood biomarkers and therapeutic targets for ALS.
first_indexed 2024-03-11T03:55:24Z
format Article
id doaj.art-1baca930541a416faf6acf008dfb9a11
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T03:55:24Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-1baca930541a416faf6acf008dfb9a112023-11-18T00:35:14ZengMDPI AGBiomedicines2227-90592023-04-01115131610.3390/biomedicines11051316Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALSMetka Ravnik Glavač0Massimo Mezzavilla1Ana Dolinar2Blaž Koritnik3Damjan Glavač4Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, SloveniaDepartment of Biology, University of Padua, 35122 Padua, ItalyDepartment of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, SloveniaInstitute of Clinical Neurophysiology, Division of Neurology, University Medical Centre Ljubljana, 1000 Ljubljana, SloveniaDepartment of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, SloveniaAmyotrophic lateral sclerosis (ALS) is a rapidly progressive adult-onset neurodegenerative disease that is often diagnosed with a delay due to initial non-specific symptoms. Therefore, reliable and easy-to-obtain biomarkers are an absolute necessity for earlier and more accurate diagnostics. Circular RNAs (circRNAs) have already been proposed as potential biomarkers for several neurodegenerative diseases. In this study, we further investigated the usefulness of circRNAs as potential biomarkers for ALS. We first performed a microarray analysis of circRNAs on peripheral blood mononuclear cells of a subset of ALS patients and controls. Among the differently expressed circRNA by microarray analysis, we selected only the ones with a host gene that harbors the highest level of conservation and genetic constraints. This selection was based on the hypothesis that genes under selective pressure and genetic constraints could have a major role in determining a trait or disease. Then we performed a linear regression between ALS cases and controls using each circRNA as a predictor variable. With a False Discovery Rate (FDR) threshold of 0.1, only six circRNAs passed the filtering and only one of them remained statistically significant after Bonferroni correction: hsa_circ_0060762 and its host gene CSE1L. Finally, we observed a significant difference in expression levels between larger sets of patients and healthy controls for both hsa_circ_0060762 and CSE1L. CSE1L is a member of the importin β family and mediates inhibition of TDP-43 aggregation; the central pathogenicity in ALS and hsa_circ_0060762 has binding sites for several miRNAs that have been already proposed as biomarkers for ALS. In addition, receiver operating characteristics curve analysis showed diagnostic potential for CSE1L and hsa_circ_0060762. Hsa_circ_0060762 and CSE1L thus represent novel potential peripheral blood biomarkers and therapeutic targets for ALS.https://www.mdpi.com/2227-9059/11/5/1316amyotrophic lateral sclerosisALScircRNAbiomarkerperipheral blood biomarkerhsa_circ_0060762
spellingShingle Metka Ravnik Glavač
Massimo Mezzavilla
Ana Dolinar
Blaž Koritnik
Damjan Glavač
Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS
Biomedicines
amyotrophic lateral sclerosis
ALS
circRNA
biomarker
peripheral blood biomarker
hsa_circ_0060762
title Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS
title_full Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS
title_fullStr Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS
title_full_unstemmed Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS
title_short Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS
title_sort aberrantly expressed hsa circ 0060762 and cse1l as potential peripheral blood biomarkers for als
topic amyotrophic lateral sclerosis
ALS
circRNA
biomarker
peripheral blood biomarker
hsa_circ_0060762
url https://www.mdpi.com/2227-9059/11/5/1316
work_keys_str_mv AT metkaravnikglavac aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals
AT massimomezzavilla aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals
AT anadolinar aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals
AT blazkoritnik aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals
AT damjanglavac aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals